Metabolic problems in recipients of liver transplants

Clinical Transplantation

Volumn 10, Issue 2, 1996, Pages 213-217

  Jindal, Rahul M ^a,b   Sidner, Richard A ^a   Hughes, Dianna ^a   Pescovitz, Mark D ^a   Leapman, Stephen B ^a   Milgrom, Martin L ^a   Lumeng, Lawrence ^a   Filo, Ronald S ^a  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cyclosporine; HLA antigens; Liver transplantation; Metabolic risk factors; Posttransplant diabetes mellitus; Posttransplant hyperlipidemia; Steroids

Indexed keywords

AZATHIOPRINE; CHOLESTEROL; CREATININE; CYCLOSPORIN; PREDNISONE; STEROID;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PRIORITY JOURNAL; PROTEINURIA; RISK;

ADULT; ANTILIPEMIC AGENTS; AZATHIOPRINE; CARBOHYDRATE METABOLISM; CREATININE; CYCLOSPORINE; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; HYPERCHOLESTEROLEMIA; HYPOGLYCEMIC AGENTS; IMMUNOSUPPRESSIVE AGENTS; INSULIN; LIVER TRANSPLANTATION; MALE; PREDNISONE; PROTEINURIA;

EID: 0029897798     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. RAINE G. Cardiovascular complicatons after renal transplantation. In: MORRIS PJ, ed. Kidney Transplantation: Principles and Practice. Philadelphia: Saunders. 1988: 575.
2. JINDAL RM. Posttransplant diabetes mellitus: A review. Transplantation 1994: 58: 1289-98.
3. DAVIS M. Immunosuppressive drugs. In: NEUBERGER J, LUCEY MR, eds. Liver transplantation: practice and management. London: BMJ. 1994: 190.
4. JINDAL RM, POPESCU I, EMRE S, et al. Serum lipid changes in liver transplant recipients in a prospective trial of cyclosporine and FK506. Transplantation 1994: 57: 1395-8.
5. GARG A. Management of dyslipidemia in IDDM patients. Diabetes Care 1994: 17: 224.
6. SVEJGAARD A, PLATZ P, RYDER LP, STAUB NIELSON L, THOMPSEN M. HLA and disease associations. A survey. Transplant Rev 1975: 22: 3-43.
7. SINHA AA, LOPEZ MT, MCDEVITT HO. Autoimmune diseases: the failure of self tolerance. Science 1990: 248: 13080-8.
8. SCHUMACHER MC, HASSTEDT SJ, HUNT SC, WILLIAMS RR, ELBEIN SC. Major gene effect for insulin levels in familial NIDDM pedigrees. Diabetes 1992: 41: 416-23.
9. SHEEHY M. HLA and insulin-dependent diabetes. Diabetes 1992: 41: 123-9.
10. SINGAL DP, BLAJCHMAN MA. Histocompatibility (HLA) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes 1973: 22: 429-32.
11. AMERICAN DIABETES ASSOCIATION. Position statement - implications of the Diabetes Control and Complications Trial. Clin Diabetes 1993: 11: 91.
12. MEJIA G. ARBELAEZ M, HENAO JE, ARANGO JL, GARCIA A. Cyclosporine-associated diabetes mellitus in renal transplants. Clin Transplant 1989: 3: 260.
13. SUMRANI NB, DELANEY V, DING Z, et al. Diabetes mellitus after renal transplantation in the cyclosporine era - An analysis of risk factors. Transplantation 1991: 51: 343.
14. JINDAL RM. EMRE S, MENESES P, et al. Diabetogenicity of FK506 versus cyclosporine in liver transplant recipients. Hepatology 1993: 18: 745A.
15. ROTH D, MILGROM M, ESQUENAZI V, FULLER L, BURKE G, MILLER J. Posttransplant hyperglycemia. Transplantation 1989: 47: 278.
16. FRIEDMAN EA, SHYH TP, BEYER MM, MANIS T, BUTT KMH. Posttransplant diabetes in kidney transplant recipients. Am J Nephrol 1985: 5: 196.
17. MOGENSEN CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med 1984: 310: 356-60.
18. DECKER T, FELDT-RASMUSSEN B, BORCH-JOHNSEN K, JENSEN T, KOFOED-ENEVOLDSEN A. Albuminuria reflects wide-spread vascular damage: the Steno hypothesis. Diabetologia 1989: 32: 219-26.
19. KNIGHT R, KERMAN RH, WELSH M, ET AL. Chronic rejection in primary cadaver renal allograft recipients under cyclosporine-prednisone immunosuppressive therapy. In: BURDICK JF, ed. Kidney Transplant rejection - Diagnosis and treatment. New York: Marcel Dekker, 1992: 627.
20. REMUZZI G, BERTANI T Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 1990: 38: 384-94.
21. NEPOM GT. A unified hypothesis for the complex genetics of HLA associations with IDDM. Diabetes 1990: 39: 1153-7.
22. D'APICE AJF, MATHEWS JD, TAIT D, KINCAID-SMITH P. Association of HLA antigens with glucose intolerance following renal transplantation. Tissue Antigens 1978: 11: 423-26.
23. MCDIARMID SV, GORNBEIN JA, FORTUNAT M, et al. Serum lipid abnormalities in pediatric liver transplant patients. Transplantation 1992: 53: 109.
24. BALLANTYNE CM, PODET EJ, PATSCH WP. et al. Effects of cyclosporine therapy on plasma lipoprotein levels. JAMA 1989: 262: 53.
25. HRICIK DE, ALMAWI W, STROM TB. Trends in the use of glucocorticoids in renal transplantation. Transplantation 1994: 57: 979.